Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M276Revenue $M7.2Net Margin (%)-1,486.9Z-Score1.7
Enterprise Value $M118EPS $-1.0Operating Margin %-1,492.6F-Score4
P/E(ttm))0Cash Flow Per Share $-1.2Pre-tax Margin (%)-1,486.9Higher ROA y-yY
Price/Book1.910-y EBITDA Growth Rate %0Quick Ratio15.6Cash flow > EarningsY
Price/Sales45.05-y EBITDA Growth Rate %0Current Ratio15.6Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-42.1Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-45.8Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M87.8ROI % (ttm)-45.0Gross Margin Increase y-yN

Gurus Latest Trades with RIGL

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
RIGLCharles Brandes 2014-09-30 Sold Out $1.97 - $3.84
($2.81)
$ 3.1512%Sold Out0
RIGLCharles Brandes 2014-03-31 Buy $2.7 - $4.75
($3.53)
$ 3.15-11%New holding, 15000 sh.15,000
RIGLGeorge Soros 2011-12-31 Sold Out -0.0019%$6.68 - $8.3
($7.59)
$ 3.15-58%Sold Out0
RIGLGeorge Soros 2011-06-30 Buy $7.18 - $9.19
($8.08)
$ 3.15-61%New holding, 14500 sh.14,500
RIGLJean-Marie Eveillard 2011-06-30 Sold Out $7.18 - $9.19
($8.08)
$ 3.15-61%Sold Out0
RIGLJean-Marie Eveillard 2011-03-31 Buy $6.54 - $7.74
($7.06)
$ 3.15-55%New holding, 46700 sh.46,700
RIGLGeorge Soros 2010-09-30 Sold Out $6.94 - $8.8
($8.11)
$ 3.15-61%Sold Out0
RIGLGeorge Soros 2010-03-31 Add$7.41 - $9.83
($8.55)
$ 3.15-63%Add 34.29%14,100
RIGLGeorge Soros 2009-12-31 Buy $6.08 - $9.86
($7.86)
$ 3.15-60%New holding, 10500 sh.10,500
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

RIGL is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


RIGL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.2241.89view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2014-12-18Sell1,000$2.2241.89view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-09-03Sell20,000$2.5623.05view
PAYAN DONALD GEVP, Pres. Discovery&Research 2014-02-24Sell20,000$3.71-15.09view
BVF PARTNERS L P/IL10% Owner 2013-11-19Sell484,622$2.6419.32view
BVF PARTNERS L P/IL10% Owner 2013-06-07Buy32,700$3.47-9.22view
VANCE DOLLYEVP Corp. Affairs, G.C., Sect. 2012-09-13Sell4,151$10.43-69.8view
Maynard Ryan DEVP & CFO 2012-09-12Sell23,302$10.67-70.48view
Maynard Ryan DEVP & CFO 2012-09-10Sell51,698$10.54-70.11view
Maynard Ryan DEVP & CFO 2012-08-07Sell1,700$10.61-70.31view

Press Releases about RIGL :

    Quarterly/Annual Reports about RIGL:

    News about RIGL:

    Articles On GuruFocus.com
    Biocept (BIOC) Soars on Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL) Mega-deal with Bris Feb 23 2015 
    Rigel Pharmaceuticals Inc. Reports Operating Results (10-K) Mar 01 2011 

    More From Our Partners
    Bristol-Myers to Buy Flexus, Team Up with Rigel - Analyst Blog Feb 24 2015 - ZACKS

    More From Other Websites
    Bristol-Myers to Buy Flexus, Team Up with Rigel - Analyst Blog Feb 24 2015
    BUZZ-U.S. STOCKS ON THE MOVE-Boeing, Digital Ally, Home Loan Servicing Feb 23 2015
    BUZZ-U.S. STOCKS ON THE MOVE-Rigel, oil stocks, Boeing Feb 23 2015
    Is Rigel Getting Enough From Bristol-Meyers? Feb 23 2015
    Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor... Feb 23 2015
    Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor... Feb 23 2015
    Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor... Feb 23 2015
    Rigel and Bristol-Myers Squibb Announce Research and Development Collaboration for TGF Beta Receptor... Feb 23 2015
    Lion Biotechnologies Appoints Ryan Maynard Director and Chair of Audit Committee Feb 17 2015
    RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Jan 30 2015
    RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Jan 09 2015
    Rigel to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 08 2015
    Rigel to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 08 2015
    Art Levinson's aging research company Calico snags South S.F. space Dec 24 2014
    RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial... Nov 24 2014
    Rigel Announces Executive Management Changes Nov 24 2014
    Rigel Announces Executive Management Changes Nov 24 2014
    RIGEL PHARMACEUTICALS INC Financials Nov 14 2014
    RIGEL PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition,... Nov 04 2014
    RIGEL PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report Nov 04 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK